Related Experiment Video
Updated: Jan 1, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
[Overview of Cancer-Associated Cachexia]
1Dept. of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Graduate School of Medical Science.
Abstract:
Cachexia is well known to be a complication with malignant disease. The frequency of cancer-associated cachexia is different among various type of cancer, and relatively high in pancreas cancer, gastric cancer or lung cancer. The typical symptoms with cancer-associated cachexia includes body weight loss, appetite loss and general fatigue. In 2011, EPCRC published the consensus report of definition for cancer-associated cachexia in 2011, and the diagnostic criteria based on body weight loss is used widely. Although the systemic inflammation complicated with cancer plays an important role for cachexia development, basic research has clarified that cancer promotes cachexia directly using proteolysis inducing factor, lipid mobilizing factor and others. Recently, anamorelin, ghrelin mimics gathers attention as a treatment drug for cancer-associated cachexia. Clinical trials confirmed that anamorelin increased the lean body mass in cancer patients probably due to improve the appetite and protein anabolism. Treatment strategy for cancer-associated cachexia needs the comprehensive approach with nutritional and exercise therapy in addition with anti-cachexia drug.
Related Concept Videos
Cancer Survival Analysis
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer

